The Central Social Insurance Medical Council, a key Japanese reimbursement policy panel better known as Chuikyo, approved an outline of…
HOME > REGULATORY
REGULATORY
- METI Budget Request Includes ¥3.3 Bil. to Promote “Healthcare Industry Creation”
October 3, 2011
- Mr Akagawa of ELD Stresses Need for Closer East Asian Cooperation to Promote Multinational Trials
October 3, 2011
- Health Insurance Committee Unable to Agree on Proposed Fixed-sum Examination Fee
October 3, 2011
- Obama Administration’s Deficit-reduction Plan Calls For Shorter Exclusivity Period for Biologics
October 3, 2011
- Nat’l Medical Expenditure Rose 3.4% to Record ¥36,006.7 Billion in FY2009: MHLW
September 30, 2011
- MHLW Drug Subcommittee Withholds Approval of Additional Indication for Epogin
September 30, 2011
- MHLW to Request Perpetuation of “Add-on Credits,” “Credits for High-level R&D Investment”
September 29, 2011
- MHLW to Request Budget of ¥29,588.2 Bil., Special Framework Budget of ¥105.9 Bil. for FY2012
September 29, 2011
- CSIMC’s Committee to Assess Premium for New Drug Development Based on Results of Market Price Survey
September 29, 2011
- Record Number of New AIDS Cases Reported in 2nd Qtr. of 2011
September 28, 2011
- MHLW Approves 18 New Products
September 27, 2011
- MHLW Asks Prefectural Authorities for Cooperation to Ensure Stable Supply of Flu Vaccine
September 27, 2011
- MHLW Announces JAN for 8 Drug Candidates
September 26, 2011
- Korosho Plans to Apply for PIC/S Membership in Early 2012
September 26, 2011
- Daiichi Sankyo Announces Approval of Silodosin in China; Aims for Launch in 2012
September 26, 2011
- Growth in Prescriptions of Prazaxa May Hit Snag Due to “Blue Letter”
September 26, 2011
- Why Generics’ Market Share Appears So Low in Japan; 20% Actually Means 35.7% if Overseas Calculation Method is Used
September 26, 2011
- Prime Minister Noda Stresses Need for Comprehensive Reform in First Major Policy Speech
September 26, 2011
- METI Seeks Budget to Collect Cancer Tissues, Genetic Data in Fukushima
September 26, 2011
- 6 APIs/10 Products Including EpiPen Added to NHI Price List
September 22, 2011
ページ
As many as 47 new drug candidates are expected to win approval or secure NHI price listing in Japan in…
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…